Unknown

Dataset Information

0

HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.

ABSTRACT: We studied the relationship between viral diversity and susceptibility to broadly neutralizing antibodies (bNAbs) in longitudinal plasma and peripheral blood mononuclear cells from 89 people with HIV who initiated antiretroviral therapy (ART) during acute and early HIV-1 infection (AEHI). HIV-1 diversity and predicted bNAb susceptibility were comparable across AEHI. Diversity evolution was not observed during ART, suggesting (pro)viruses at initiation or during treatment may identify individuals with susceptible virus for bNAb interventional trials.

SUBMITTER: VanderVeen LA 

PROVIDER: S-EPMC10906214 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

We studied the relationship between viral diversity and susceptibility to broadly neutralizing antibodies (bNAbs) in longitudinal plasma and peripheral blood mononuclear cells from 89 people with HIV who initiated antiretroviral therapy (ART) during acute and early HIV-1 infection (AEHI). HIV-1 diversity and predicted bNAb susceptibility were comparable across AEHI. Diversity evolution was not observed during ART, suggesting (pro)viruses at initiation or during treatment may identify individuals  ...[more]

Similar Datasets

Unknown Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies.
| S-EPMC11347675 | biostudies-literature
Unknown Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies.
| S-EPMC10515946 | biostudies-literature
Unknown Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
| S-EPMC8606870 | biostudies-literature
Other Vaccination elicits HIV broadly neutralizing antibodies in primates
2026-06-24 | GSE326649 | GEO
Unknown Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
| S-EPMC2965066 | biostudies-literature
Unknown Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection.
| S-EPMC9769376 | biostudies-literature
Unknown Broadly neutralizing antibodies for the treatment and prevention of HIV infection.
| S-EPMC7340121 | biostudies-literature
Unknown Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo.
| S-EPMC4750682 | biostudies-literature
Unknown Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
| S-EPMC10865826 | biostudies-literature
Unknown Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.
| S-EPMC2951345 | biostudies-literature